AGTR1 and osteoarthritis: Angiotensin II (Ang II), by activating the angiotensin II type 1 receptor (AGTR1), leads to pathological changes in the knee joints of experimental osteoarthritis mice, such as articular cartilage degradation, subchondral bone sclerosis, inflammation, and synovial damage.